AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 67 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $612,078 | -1.1% | 262,694 | +1.0% | 0.07% | -25.3% |
| Q2 2023 | $619,006 | +29.3% | 260,087 | 0.0% | 0.10% | -9.2% |
| Q1 2023 | $478,559 | -3.2% | 260,087 | 0.0% | 0.11% | -8.4% |
| Q4 2022 | $494,166 | -11.1% | 260,087 | 0.0% | 0.12% | +7.2% |
| Q3 2022 | $556,000 | -39.0% | 260,087 | -19.3% | 0.11% | -33.1% |
| Q2 2022 | $912,000 | -41.2% | 322,217 | -13.4% | 0.17% | -18.6% |
| Q1 2022 | $1,552,000 | -45.1% | 372,217 | -31.7% | 0.20% | -51.5% |
| Q4 2021 | $2,827,000 | -20.8% | 544,819 | 0.0% | 0.42% | +67.7% |
| Q3 2021 | $3,568,000 | -60.4% | 544,819 | -59.8% | 0.25% | -65.5% |
| Q2 2021 | $9,004,000 | +25.1% | 1,356,048 | +8.0% | 0.73% | +200.8% |
| Q1 2021 | $7,196,000 | – | 1,256,048 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 21,346,829 | $49,738,112 | 74.10% |
| TFG Asset Management GP Ltd | 12,000,000 | $27,960,000 | 5.10% |
| Paradigm Biocapital Advisors LP | 14,406,782 | $33,567,802 | 2.28% |
| Lynx1 Capital Management LP | 1,363,025 | $3,175,848 | 2.10% |
| Deep Track Capital, LP | 15,000,000 | $34,950,000 | 1.35% |
| Affinity Asset Advisors, LLC | 1,992,466 | $4,642,446 | 1.31% |
| DAFNA Capital Management LLC | 928,253 | $2,162,829 | 0.67% |
| Frazier Life Sciences Management, L.P. | 3,746,857 | $8,730,177 | 0.58% |
| ARMISTICE CAPITAL, LLC | 6,900,000 | $16,077,000 | 0.25% |
| Blackstone Inc. | 20,485,611 | $47,731,474 | 0.20% |